Published in Nat Rev Cardiol on November 22, 2011
Neighborhoods, obesity, and diabetes--a randomized social experiment. N Engl J Med (2011) 5.72
Racial profiling in medical research. N Engl J Med (2001) 3.25
Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med (2010) 2.78
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension (2010) 2.47
Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Genet (2009) 2.31
South Asians and cardiovascular risk: what clinicians should know. Circulation (2006) 1.74
Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions. Circulation (2011) 1.71
Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction. Circ Cardiovasc Genet (2010) 1.16
Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc (2011) 1.00
Treatment of heart failure in African Americans: a consensus statement. Congest Heart Fail (2010) 0.99
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol (2008) 1.50
Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep (2014) 1.08
Clinical implications of clopidogrel resistance. Thromb Haemost (2008) 1.01
TGF-beta1: a novel target for cardiovascular pharmacology. Cytokine Growth Factor Rev (2007) 0.99
Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta. Circulation (2003) 0.97
Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanism. Diabetes (2005) 0.94
Thrombi of different pathologies: implications for diagnosis and treatment. Curr Treat Options Cardiovasc Med (2010) 0.93
Cyclosporine before PCI in Acute Myocardial Infarction. N Engl J Med (2016) 0.92
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type). Atherosclerosis (2011) 0.91
Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux. Curr Atheroscler Rep (2011) 0.85
Niacin for reduction of cardiovascular risk. N Engl J Med (2014) 0.84
[Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going?]. Rev Esp Cardiol (2010) 0.79
High-density lipoprotein and cardiovascular risk reduction: promises and realities. Rev Esp Cardiol (Engl Ed) (2012) 0.78
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term. Thromb Haemost (2012) 0.78
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis. Atherosclerosis (2008) 0.77
Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration. J Cardiovasc Pharmacol (2011) 0.77
[Improvements in oral anticoagulant therapy for atrial fibrillation]. Med Clin (Barc) (2013) 0.76
Reply: platelets interplay between pneumonia and cardiovascular events: establishing a link? J Am Coll Cardiol (2015) 0.75
Role of HDL in those with diabetes. Curr Cardiol Rep (2014) 0.75